PlainRecalls
FDA Drug Moderate Class II Terminated

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reported: December 30, 2020 Initiated: December 10, 2020 #D-0172-2021

Product Description

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reason for Recall

Subpotent Drug: Low out-of-specification assay results for the epinephrine component.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
4411 trays
Distribution
Nationwide in the USA
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.. Recalled by Fresenius Kabi USA, LLC. Units affected: 4411 trays.
Why was this product recalled?
Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 30, 2020. Severity: Moderate. Recall number: D-0172-2021.